# Elicio Therapeutics, Inc.: Form 8-K, filed Jan 30, 2025

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2025-01-30
- Accepted by EDGAR: Jan 30, 2025, 09:03 ET
- Period: 2025-01-29
- Accession: 0001193125-25-016455
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000119312525016455/d914999d8k.htm

Filed Jan 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-016455. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.